<DOC>
	<DOCNO>NCT00311012</DOCNO>
	<brief_summary>This study evaluate efficacy SPP100 lower blood pressure patient essential hypertension .</brief_summary>
	<brief_title>SPP100 Dose Finding Study Japan</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<criteria>1 . Mild moderate essential hypertension 2 . Age : ≥20 year old &lt; 80 year old ( time inform consent obtain ) 3 . Sex : N/A 4 . Admission status : Outpatient 1 . Pregnant woman , lactate woman , potentially pregnant woman , woman wish become pregnant 2 . Patients mean sit diastolic blood pressure ≥110 mmHg and/or mean sit systolic blood pressure ≥180 mmHg either Visit 2 3 3 . Patients secondary hypertension complication patient suspect secondary hypertension ( due aortic coarctation , primary aldosteronism , coarctation renal artery , renal hypertension 4 . Patients suspect malignant hypertension</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2006</verification_date>
	<keyword>Hypertension , Aliskiren</keyword>
</DOC>